Cell Death & Differentiation , 16(10): 1303-1314 James, S.J., Slikker, W
(Yale University) There is clear evidence in adults with T1D that GLP-1 receptor agonists can improve weight and glycemic control and reduce the risk of heart and kidney complications, and more clinical evidence is needed for the adolescent population
Studies indicate that the glycosylation, SIRT5-mediated deglutarylation and SIRT2-mediated deacetylation all enhance G6PD activity and maintain cellular NADPH homeostasis
GHK-Cu is believed to work by binding to copper ions and activating various biological pathways, including the promotion of antioxidant activity, modulation of the immune response, and stimulation of cell proliferation and differentiation
Reducing the risk of metabolic diseases: Inhibiting NNMT may counteract the adverse metabolic changes associated with obesity, such as fatty liver disease
- ,